The NSD family of protein methyltransferases in human cancer.
about
Epigenetic modulators, modifiers and mediators in cancer aetiology and progressionDysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapyStructural basis for PHDVC5HCHNSD1-C2HRNizp1 interaction: implications for Sotos syndrome.Automethylation of SUV39H2, an oncogenic histone lysine methyltransferase, regulates its binding affinity to substrate proteinsWHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck.WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer.Marked for death: targeting epigenetic changes in cancer.SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells.Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small-cell lung cancer cells.Whole-exome sequencing reveals novel mutations and epigenetic regulation in hypopharyngeal carcinoma.The methyltransferase NSD3 promotes antiviral innate immunity via direct lysine methylation of IRF3.Wolf-Hirschhorn syndrome candidate 1-like 1 epigenetically regulates nephrin gene expression.Setd2 regulates quiescence and differentiation of adult hematopoietic stem cells by restricting RNA polymerase II elongation.Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.The role of histone lysine methyltransferase NSD3 in cancerCancer- and behavior-related genes are targeted by selection in the Tasmanian devil (Sarcophilus harrisii)
P2860
Q26766149-DB1C93F6-8E30-4902-9DF5-E085B7E90353Q26769943-8494932B-3750-4276-B1F2-1C38101F5771Q36817971-8001A31E-604A-410C-B586-0471FFFEB595Q37225691-B60DF88B-B6D1-40E5-B99C-50711EC6C2FEQ37520610-B1BEE342-1B7B-48B2-A0CA-7E85637E42A3Q37593319-B9F59D76-D73D-4DA4-859E-2CE05074761AQ38747872-15EB71E9-8A20-4798-97A8-CDFB748E6EDCQ38818202-78212F45-B6EE-4C0E-AC7D-C88688CD53B8Q38975402-29C599FC-593B-490A-ABF4-98B9BE443A64Q41072068-FD5339B3-A7FE-4631-A89A-F9E31F2CF877Q47094013-6FD6655C-B24F-4C43-8361-631D87DA8FB8Q47443018-9D7BE5A5-99CD-4BED-B3B8-23DCB6729DA1Q51126964-91F2ACA7-8C68-4926-82F5-C680C6FA6456Q52323123-A6762F77-55A5-4C58-BC60-CFB5C24F6BD2Q52596648-D1BBD616-214F-4C1B-98C6-49EED648EE01Q57177118-10C6BFA4-12C2-4378-98EE-2079F3C012E1Q58787210-81FA1AA2-3F1A-4D97-8E82-3047B0C0052B
P2860
The NSD family of protein methyltransferases in human cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The NSD family of protein methyltransferases in human cancer.
@en
type
label
The NSD family of protein methyltransferases in human cancer.
@en
prefLabel
The NSD family of protein methyltransferases in human cancer.
@en
P2093
P2860
P356
P1433
P1476
The NSD family of protein methyltransferases in human cancer.
@en
P2093
Ryuji Hamamoto
Theodore Vougiouklakis
Vassiliki Saloura
Yusuke Nakamura
P2860
P304
P356
10.2217/EPI.15.32
P577
2015-05-05T00:00:00Z